← Evidence map

ArticleBiomolecules2025

Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity.

Mark Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41154699